- Investing Ideas
- /
- Hong Kong Healthcare Undervalued Stocks Based On Cash Flows
Hong Kong Healthcare Undervalued Stocks Based On Cash Flows
Results
6
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
6 companies
YSB
Market Cap: HK$6.2b
Develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China.
9885
HK$9.11
7D
-10.3%
1Y
26.7%
Shanghai Conant Optical
Market Cap: HK$21.6b
Manufactures and sells resin spectacle lenses in Mainland China, the Americas, Asia, Europe, Oceania, and Africa.
2276
HK$45.02
7D
7.3%
1Y
198.5%
MicroPort CardioFlow Medtech
Market Cap: HK$2.9b
A medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally.
2160
HK$1.19
7D
-2.5%
1Y
65.3%
MicroPort NeuroScientific
Market Cap: HK$6.8b
Provides neuro-interventional medical devices.
2172
HK$11.85
7D
2.4%
1Y
27.3%
Zylox-Tonbridge Medical Technology
Market Cap: HK$7.5b
A medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People’s Republic of China and internationally.
2190
HK$23.66
7D
2.5%
1Y
106.5%
LEPU ScienTech Medical Technology (Shanghai)
Market Cap: HK$6.5b
An investment holding company, engages in the manufacture and sale of interventional treatment series occluders for defective congenital heart disease.
2291
HK$18.80
7D
-0.6%
1Y
11.9%